Edition:
United Kingdom

AngioDynamics Inc (ANGO.OQ)

ANGO.OQ on NASDAQ Stock Exchange Global Select Market

20.37USD
23 May 2018
Change (% chg)

$0.24 (+1.19%)
Prev Close
$20.13
Open
$20.02
Day's High
$20.53
Day's Low
$20.02
Volume
61,229
Avg. Vol
79,601
52-wk High
$20.70
52-wk Low
$14.97

Chart for

About

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $625.27
Shares Outstanding(Mil.): 36.72
Dividend: --
Yield (%): --

Financials

  ANGO.OQ Industry Sector
P/E (TTM): 178.12 32.19 32.75
EPS (TTM): 0.10 -- --
ROI: 0.57 13.89 14.38
ROE: 0.71 16.72 16.07

BRIEF-AngioDynamics Q3 Earnings Per Share $0.37

* ANGIODYNAMICS REPORTS FISCAL 2018 THIRD QUARTER FINANCIAL RESULTS

29 Mar 2018

BRIEF-Angiodynamics Receives FDA Expedited Access Pathway Designation For Nanoknife System For Treatment Of Stage III Pancreatic Cancer

* ANGIODYNAMICS RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR THE NANOKNIFE® SYSTEM FOR THE TREATMENT OF STAGE III PANCREATIC CANCER

24 Jan 2018

BRIEF-AngioDynamics Says U.S. Tax Reform To Have Impact Of $0.02- $0.04 On Non-GAAP Adjusted EPS In FY 2018

* ANGIODYNAMICS SAYS U.S. TAX REFORM ACT TO HAVE AN IMPACT IN RANGE OF $0.02- $0.04 ON NON-GAAP ADJUSTED EPS IN FY 2018 -SEC FILING Source: (http://bit.ly/2mfAFmM) Further company coverage:

10 Jan 2018

BRIEF-AngioDynamics Q2 GAAP Earnings Per Share $0.01

* ANGIODYNAMICS REPORTS FISCAL 2018 SECOND QUARTER FINANCIAL RESULTS

04 Jan 2018

Earnings vs. Estimates